Medtech Ventures is a European private equity and venture capital investment firm with a dedicated focused on game changing technologies. Medtech Ventures publishes forward looking strategic opportunity studies covering high growth niche areas within the medical technology space.
Jan 01, 2020 | Published by: Medtech Ventures | USD 980
Immune Checkpoint Inhibitors Global immune checkpoint inhibitors market reached $22 billion in 2019, quite a growth giving the fact that the first product in this new class of therapeutics was launched just 9 years ago and the market was valued at $360 million in 2011. The market took off in 2015, t ... Read More